Summit 2022 vs Updates in NHL Management Usage & Stats

Dear Colleagues, Summit 2022 is the 9th joint project of EHOG and MD Anderson Cancer Center Leukemia Department that will take place on May, 7-8 in İstanbul. We are extremely happy to be able to organize this meeting in person after two years due to the pandemic. As every year, distinguished MD Anderson Cancer CenterLeukemia Department physicians along with the other distinguished speakers from Europe will present their latest research findings and perspectives on the hematologic diseases at this two-day meeting. The concept of the meeting is based on interactive presentations where the audience will be able to ask online questions to the speakers. Looking forward to welcoming you to beautiful Istanbul. On behalf of the Organizing Committee, Prof. Birol Güvenç, MD
  • Apple App Store
  • Free
  • Medical

Store Rank

- -

In the management of non-Hodgkin lymphoma (NHL), multiple mechanisms of therapy have been developed. These therapies include anti-CD20 antibodies and chimeric antigen receptor T-cell (CAR-T) therapies. With continued developments in NHL management, bispecific antibodies are a promising strategy for use in the relapsed/refractory setting with promising data showing potential for improving outcomes in patient care.
  • Apple App Store
  • Free
  • Medical

Store Rank

- -

Summit 2022 vs. Updates in NHL Management ranking comparison

Compare Summit 2022 ranking trend in the past 28 days vs. Updates in NHL Management

Rank

No Data Available

Summit 2022 vs. Updates in NHL Management ranking by country comparison

Compare Summit 2022 ranking trend in the past 28 days vs. Updates in NHL Management

No Data to Display

Compare to any site with our free trial

Get started
Summit 2022 VS.
Updates in NHL Management

December 15, 2024